Evidence map›Paper›PMID 19965504›Full record

ArticleScience (New York, N.Y.)2009

How telomeres solve the end-protection problem.

Titia de Lange

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 491 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
491citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

491 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

431 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Titia de LangeLaboratory of Cell Biology and Genetics, Rockefeller University, New York, NY 10021, USA. delange@mail.rockefeller.edu

Funding

MECHANISMS OF TELOMERE INDUCED SENESCENCER01AG016642 · NIA · ROCKEFELLER UNIVERSITY · PI Titia de Lange · 1999 to 2026
$11.9M
Molecular Cytology of Human Telomeres: Telomere proteinR37GM049046 · NIGMS · ROCKEFELLER UNIVERSITY · PI DE LANGE, TITIA · 2005 to 2014
$5.0M
TELOMERE LENGTH CONTROL BY TRF1 AND TRF2R01CA076027 · NCI · ROCKEFELLER UNIVERSITY · PI DE LANGE, TITIA · 1998 to 2012
$4.3M
NIH Director's Pioneer Award (RMI)DP1OD000379 · OD · ROCKEFELLER UNIVERSITY · PI DE LANGE, TITIA · 2005 to 2009
$4.1M
MOLECULAR CYTOLOGY OF HUMAN TELOMERES--TELOMERE PROTEINR01GM049046 · NIGMS · ROCKEFELLER UNIVERSITY · PI DE LANGE, TITIA · 1993 to 2004
$1.8M
Mechanism of the telomeric proliferation limitR56AG016642 · NIA · ROCKEFELLER UNIVERSITY · PI DE LANGE, TITIA · 2019 to 2019
$598k
NCI NIH HHS CA076027NCI NIH HHS R01 CA076027NIA NIH HHS AG016642NIA NIH HHS R01 AG016642NIA NIH HHS R56 AG016642NIGMS NIH HHS GM049046NIGMS NIH HHS R01 GM049046NIGMS NIH HHS R37 GM049046NIH HHS DP1 OD000379
6 · The paper itself

Abstract

The ends of eukaryotic chromosomes have the potential to be mistaken for damaged or broken DNA and must therefore be protected from cellular DNA damage response pathways. Otherwise, cells might permanently arrest in the cell cycle, and attempts to "repair" the chromosome ends would have devastating consequences for genome integrity. This end-protection problem is solved by protein-DNA complexes called telomeres. Studies of mammalian cells have recently uncovered the mechanism by which telomeres disguise the chromosome ends. Comparison to unicellular eukaryotes reveals key differences in the DNA damage response systems that inadvertently threaten chromosome ends. Telomeres appear to be tailored to these variations, explaining their variable structure and composition.

Indexed as

AnimalsChromosomesChromosomes, MammalianCiliophoraDNADNA-Binding ProteinsDNA DamageDNA RepairHumansRepetitive Sequences, Nucleic AcidShelterin ComplexSignal TransductionTelomeraseTelomereTelomere-Binding ProteinsTelomeric Repeat Binding Protein 2DNADNA-Binding ProteinsPOT1 protein, humanPOT1 protein, mouseShelterin ComplexTelomeraseTelomere-Binding ProteinsTelomeric Repeat Binding Protein 2

Identifiers

PMID19965504
PMCPMC2819049

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.